Influence of Endoplasmic Reticulum Aminopeptidase 1 Gene Variants on Liver Fibrosis Progression in Patients with HCV Chronic Infection

2019 ◽  
Author(s):  
Jose Ramón Vidal-Castiñeira ◽  
Antonio López-Vázquez ◽  
Paula Diaz-Bulnes ◽  
Susana Díaz-Coto ◽  
Leonardo Márquez-Kisinousky ◽  
...  
2020 ◽  
Vol 98 (9) ◽  
pp. 1245-1254
Author(s):  
Jose Ramón Vidal-Castiñeira ◽  
Antonio López-Vázquez ◽  
Paula Diaz-Bulnes ◽  
Susana Díaz-Coto ◽  
Leonardo Márquez-Kisinousky ◽  
...  

2014 ◽  
Vol 15 (S8) ◽  
Author(s):  
James Lara ◽  
F Xavier López-Labrador ◽  
Fernando González-Candelas ◽  
Marina Berenguer ◽  
Yury E Khudyakov

2019 ◽  
Vol 116 (52) ◽  
pp. 26709-26716 ◽  
Author(s):  
Petros Giastas ◽  
Anastasia Mpakali ◽  
Athanasios Papakyriakou ◽  
Aggelos Lelis ◽  
Paraskevi Kokkala ◽  
...  

Endoplasmic reticulum aminopeptidase 1 (ERAP1) is an intracellular enzyme that optimizes the peptide cargo of major histocompatibility class I (MHC-I) molecules and regulates adaptive immunity. It has unusual substrate selectivity for length and sequence, resulting in poorly understood effects on the cellular immunopeptidome. To understand substrate selection by ERAP1, we solved 2 crystal structures of the enzyme with bound transition-state pseudopeptide analogs at 1.68 Å and 1.72 Å. Both peptides have their N terminus bound at the active site and extend away along a large internal cavity, interacting with shallow pockets that can influence selectivity. The longer peptide is disordered through the central region of the cavity and has its C terminus bound in an allosteric pocket of domain IV that features a carboxypeptidase-like structural motif. These structures, along with enzymatic and computational analyses, explain how ERAP1 can select peptides based on length while retaining the broad sequence-specificity necessary for its biological function.


Sign in / Sign up

Export Citation Format

Share Document